NCT04222634View on ClinicalTrials.gov

Metastasis-directed Therapy in Castration-refractory Prostate Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 27, 2019

Primary Completion Date

July 25, 2023

Study Completion Date

January 1, 2030

Conditions
Castration-resistant Prostate Cancer
Interventions
OTHER

Radiotherapy (SBRT) and/or surgery (metastasectomy)

Metastasis-directed therapy (surgery and/or radiotherapy) as treatment for oligoprogressive lesions

Trial Locations (1)

3000

Gert De Meerleer, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER